Advances in thymic carcinoma diagnosis and treatment: a review of literature

Thymomas account for up to 50 % of anterior mediastinal neoplasms with an incidence of 0.13 per 100,000 person-years in the USA. Thymic carcinoma is a rare malignancy of the thymus gland distinguished from thymomas as it has a more invasive and metastasizing potential conferring poor prognosis. Due...

Full description

Saved in:
Bibliographic Details
Published in:Medical oncology (Northwood, London, England) London, England), 2014-07, Vol.31 (7), p.44-44, Article 44
Main Authors: Syrios, J., Diamantis, N., Fergadis, E., Katsaros, L., Logothetis, M., Iakovidou, Ι., Lianos, E., Grivas, A., Athanasiou, A. E.
Format: Article
Language:English
Subjects:
Chemotherapy, Adjuvant
Hematology
Humans
Internal Medicine
Medicine
Medicine & Public Health
Molecular Targeted Therapy
Neoadjuvant Therapy
Oncology
Pathology
Prognosis
Review Article
Thymus Neoplasms - diagnosis
Thymus Neoplasms - pathology
Thymus Neoplasms - therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Thymomas account for up to 50 % of anterior mediastinal neoplasms with an incidence of 0.13 per 100,000 person-years in the USA. Thymic carcinoma is a rare malignancy of the thymus gland distinguished from thymomas as it has a more invasive and metastasizing potential conferring poor prognosis. Due to the rarity of thymic carcinoma and the great variety of its histological subtypes, there is no solid evidence on optimal staging, imaging and treatment guidelines. Herein, we systematically review the literature on current clinical practice with regard to diagnostic evaluation, histopathological assessment, management and treatment of squamous thymic carcinoma.
ISSN:1357-0560
1559-131X
DOI:10.1007/s12032-014-0044-2